E-LIB Suche - Ergebnisse für: Berghella, Anna Maria

1

Personalized Prevention Strategies to Defeat Cancer:

, In: Cancer Immunology,

Berghella, Anna Maria ; Aureli, Anna ; Canossi, Angelica... - p. 41-51 , 2020

Link: https://doi.org/10.1007/..

2

Ageing gender-specific "Biomarkers of Homeostasis", to prot..:

Berghella, Anna Maria ; Contasta, Ida ; Marulli, Giuseppe...
Immunity & Ageing. 11 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

3

The discovery of how gender influences age immunological me..:

Berghella, Anna Maria ; Contasta, Ida ; Del Beato, Tiziana.
Immunity & Ageing. 9 (2012) 1 - p. , 2012

Link: https://doi.org/10.1186/..

4

A gender-related action of IFNbeta-therapy was found in mul..:

Contasta, Ida ; Totaro, Rocco ; Pellegrini, Patrizia...
Journal of Translational Medicine. 10 (2012) 1 - p. , 2012

Link: https://doi.org/10.1186/..

5

Gender-Specific Cytokine Pathways, Targets, and Biomarkers ..:

Pellegrini, Patrizia ; Contasta, Ida ; Del Beato, Tiziana..
Clinical and Developmental Immunology. 2011 (2011) - p. 1-16 , 2011

Link: https://doi.org/10.1155/..

6

The potential role of thioredoxin 1 and CD30 systems as mul..:

Berghella, Anna Maria ; Pellegrini, Patrizia ; Del Beato, Tiziana..
Cancer Immunology, Immunotherapy. 60 (2011) 10 - p. 1373-1381 , 2011

Link: https://doi.org/10.1007/..

7

IFN??-1a Treatment and Reestablishment of Th1 Regulation in..:

Pellegrini, Patrizia ; Totaro, Rocco ; Contasta, Ida...
Clinical Neuropharmacology. 27 (2004) 6 - p. 258-269 , 2004

Link: https://doi.org/10.1097/..

8

Passage from Normal Mucosa to Adenoma and Colon Cancer: Alt..:

Contasta, Ida ; Berghella, Anna Maria ; Pellegrini, Patrizia.
Cancer Biotherapy and Radiopharmaceuticals. 18 (2003) 4 - p. 549-557 , 2003

Link: https://doi.org/10.1089/..

9

CD30 antigen: not a physiological marker for TH2 cells but ..:

Pellegrini, Patrizia ; Berghella, Anna Maria ; Contasta, Ida.
Transplant Immunology. 12 (2003) 1 - p. 49-61 , 2003

Link: https://doi.org/10.1016/..

10

Peripheral Blood Immunological Parameters for Use as Marker..:

Berghella, Anna Maria ; Contasta, Ida ; Pellegrini, Patrizia..
Cancer Biotherapy and Radiopharmaceuticals. 17 (2002) 1 - p. 43-50 , 2002

Link: https://doi.org/10.1089/..

11

Cell Cycle Control in Cellular Homeostasis During the Immun..:

Contasta, Ida ; Pellegrini, Patrizia ; Berghella, Anna Maria.
Cancer Biotherapy and Radiopharmaceuticals. 16 (2001) 1 - p. 63-71 , 2001

Link: https://doi.org/10.1089/..

12

The TH1 and TH2 Cytokine Network in Healthy Subjects: Sugge..:

Pellegrini, Patrizia ; Contasta, Ida ; Berghella, Anna Maria...
Cancer Biotherapy and Radiopharmaceuticals. 15 (2000) 3 - p. 267-278 , 2000

Link: https://doi.org/10.1089/..

13

Simultaneous measurement of soluble carcinoembryonic antige..:

Pellegrini, Patrizia ; Contasta, Ida ; Berghella, Anna Maria...
Cancer Immunology, Immunotherapy. 49 (2000) 7 - p. 388-394 , 2000

Link: https://doi.org/10.1007/..

14

Relationships Between the Activity of MMP1/TIMP1 Enzymes an..:

Contasta, Ida ; Berghella, Anna Maria ; Pellegrini, Patrizia...
Cancer Biotherapy and Radiopharmaceuticals. 14 (1999) 6 - p. 465-475 , 1999

Link: https://doi.org/10.1089/..

15

Disease Stage Prognostic Indices in the Early Clinical Scre..:

Pellegrini, Patrizia ; Berghella, Anna Maria ; Del Beato, Tiziana...
Cancer Biotherapy and Radiopharmaceuticals. 13 (1998) 2 - p. 89-98 , 1998

Link: https://doi.org/10.1089/..